Trial intelligence / Profile preview

Oral clonidine for reducing bleeding during pelvic and acetabular fracture surgery

IRCT20150221021171N2Phase 2Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, triple-blind trial of clonidine in pelvic fracture and acetabular fracture (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Amount of bleeding. Started Mar 2022; status: completed.

02

Drugs

clonidine
03

Conditions

pelvic fractureacetabular fracture

Beyond the preview

Go deeper on IRCT20150221021171N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20150221021171N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call